Concepedia

Author

Lisa Rossius

Bayreuth Medical Center

Also Known As

Lisa Rossius

3

Publications

2.2K

Citations

3

H-Index

13

Concepts

All Affiliations

Bayreuth Medical CenterLudwig-Maximilians-Universität MünchenLukaskrankenhausKrankenhaus NordwestKlinikum St. Marien Amberg
LR

About

Lisa Rossius is an author at Bayreuth Medical Center specializing in colorectal cancer, cancer therapeutics, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

2.2K

2

Pathology

3

3

2.2K

3

Health Sciences

1

1

1.7K

4

Cancer Cell Biology

1

1

97

5

Cancer Genetics

1

1

97

Lisa Rossius

×

3

Publications

2.2K

Citations

3

H-Index

YearCitations

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker,

The Lancet Oncology

2014

1.7K

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial

Sebastian Stintzing, Dominik Paul Modest, Lisa Rossius,

The Lancet Oncology

2016

410

Mutations within the EGFR signaling pathway: Influence on efficacy in FIRE-3—A randomized phase III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild-type (WT) KRAS (exon 2) metastatic colorectal cancer (mCRC) patients.

Sebastian Stintzing, Andreas Jung, Lisa Rossius,

Journal of Clinical Oncology

2014

97

Page 1